Depending on the cohorts, the contribution of SRG mutations in monogenic pulmonary fibrosis ranges from 2 to 5%, with the exception of some populations where it may reach 25% in chILD [10,26,74,100,101,102,103,104]. Here, CASZ1 is linked to pulmonary fibrosis.